المؤلفون: Maria Paola Anolli, Elisabetta Degasperi, Lena Allweiss, Angelo Sangiovanni, Marco Maggioni, Caroline Scholtes, Valerie Oberhardt, Christoph Neumann-Haefelin, Maura Dandri, Fabien Zoulim, Pietro Lampertico

المساهمون: M.P. Anolli, E. Degasperi, L. Allwei, A. Sangiovanni, M. Maggioni, C. Scholte, V. Oberhardt, C. Neumann-Haefelin, M. Dandri, F. Zoulim, P. Lampertico

مصطلحات موضوعية: Bulevirtide, clinically significant portal hypertension, compensated cirrhosi, HBcrAg, HBV, HDV, HDV RNA, liver fibrosi, PBMC, sustained virological response, Settore MED/12 - Gastroenterologia

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36931396; info:eu-repo/semantics/altIdentifier/wos/WOS:000956003500001; volume:78; issue:4; firstpage:876; lastpage:880; numberofpages:5; journal:JOURNAL OF HEPATOLOGY; https://hdl.handle.net/2434/1001411Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85151328707

الإتاحة: https://doi.org/10.1016/j.jhep.2022.12.023Test
https://hdl.handle.net/2434/1001411Test

المؤلفون: Elisabetta Degasperi, Maria P. Anolli, Pietro Lampertico

المصدر: Liver international : official journal of the International Association for the Study of the LiverREFERENCES.

مصطلحات موضوعية: Settore MED/12 - Gastroenterologia, chronic delta hepatitis, Hepatology, HDV-RNA, HDV, combined response, virological response, Bulevirtide, clinically significant portal hypertension, compensated cirrhosis, entry inhibitor

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbfc39d2fcf9f87dc1873dbbcbe1bc9bTest
https://pubmed.ncbi.nlm.nih.gov/35942695Test

المؤلفون: Lampertico P., Roulot D., Wedemeyer H.

المساهمون: P. Lampertico, D. Roulot, H. Wedemeyer

مصطلحات موضوعية: Bulevirtide, chronic hepatits Delta, clinically significant portal hypertension, combined response, compensated cirrhosi, Entry inhibitor, HDV, HDV ribonucleic acid, HDV RNA, hepatitis D viru, virological response, Adult, Human, Hepatitis Delta Viru, Interferon-alpha, Liver Cirrhosi, Polyethylene Glycol, Clinical Trials, Phase III as Topic, Phase II as Topic, Drug Therapy, Combination, Antiviral Agent, Hepatitis D, Chronic, Lipopeptides, Settore MED/12 - Gastroenterologia

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35752223; info:eu-repo/semantics/altIdentifier/wos/WOS:000877324300004; volume:77; issue:5; firstpage:1422; lastpage:1430; numberofpages:9; journal:JOURNAL OF HEPATOLOGY; https://hdl.handle.net/2434/1001396Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85135090491

الإتاحة: https://doi.org/10.1016/j.jhep.2022.06.010Test
https://hdl.handle.net/2434/1001396Test

المؤلفون: Degasperi E, Anolli MP, Uceda Renteria SC, Sambarino D, Borghi M, Perbellini R, Scholtes C, Facchetti F, Loglio A, Monico S, Fraquelli M, Costantino A, Ceriotti F, Zoulim F, Lampertico P.

المساهمون: E. Degasperi, M. Anolli, S.C. UCEDA RENTERIA, D. Sambarino, M. Borghi, R. Perbellini, C. Scholte, F. Facchetti, A. Loglio, S. Monico, M. Fraquelli, A. Costantino, F. Ceriotti, F. Zoulim, P. Lampertico

مصطلحات موضوعية: Bulevirtide, Entry inhibitor, HBV, HBV RNA, HBcrAg, HDV, HDV RNA, clinically significant portal hypertension, compensated cirrhosis, Settore MED/12 - Gastroenterologia

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35973578; info:eu-repo/semantics/altIdentifier/wos/WOS:000928043800008; volume:77; issue:6; firstpage:1525; lastpage:1531; numberofpages:7; journal:JOURNAL OF HEPATOLOGY; https://hdl.handle.net/2434/1010297Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85137654340

الإتاحة: https://doi.org/10.1016/j.jhep.2022.07.016Test
https://hdl.handle.net/2434/1010297Test